News
WALTHAM, Mass., Jan. 15, 2025 /PRNewswire/ -- Alcresta Therapeutics, Inc., a leading commercial-stage company focused on developing and commercializing novel enzyme-based products, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback